Brought to you by 
Becton Dickinson withdraws deal for Cygnus' GlucoWatch
13 Jul 1999
Executive Summary
Becton Dickinson has signed an agreement with Cygnus (transdermal drug delivery systems) to market its GlucoWatch, a continuous glucose monitoring device.
Deal Industry
- In Vitro Diagnostics
Deal Status
- Terminated
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Becton Dickinson withdraws deal for Cygnus' GlucoWatch
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice